Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchoscopic cholestin vs standard treatment for ventilator-associated pneumonia
IRCT20120527009886N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Xuezhikang in ventilator-associated pneumonia (VAP) (3 arms), sponsored by Tehran University of Medical Sciences. Started Apr 2023; status: completed.
02
Drugs
Xuezhikang
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20120527009886N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120527009886N3.